An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England: A Policy Modeling Study

被引:73
|
作者
Collins, Marissa [1 ]
Mason, Helen [1 ]
O'Flaherty, Martin [2 ]
Guzman-Castillo, Maria [2 ]
Critchley, Julia [3 ]
Capewell, Simon [2 ]
机构
[1] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow G4 0BA, Lanark, Scotland
[2] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England
[3] Univ London, Div Populat Hlth Sci & Educ PHSE St Georges, London, England
基金
英国医学研究理事会;
关键词
cardiovascular disease; economic evaluation; population health; salt; UK policy; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; CASE-FATALITY; PREVENTION; TRENDS; WALES;
D O I
10.1016/j.jval.2014.03.1722
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Dietary salt intake has been causally linked to high blood pressure and increased risk of cardiovascular events. Cardiovascular disease causes approximately 35% of total UK deaths, at an estimated annual cost of 30 billion. The World Health Organization and the National Institute for Health and Care Excellence have recommended a reduction in the intake of salt in people's diets. This study evaluated the cost-effectiveness of four population health policies to reduce dietary salt intake on an English population to prevent coronary heart disease (CHD). Methods: The validated IMPACT CHD model was used to quantify and compare four policies: 1) Change4Life health promotion campaign, 2) front-of-pack traffic light labeling to display salt content, 3) Food Standards Agency working with the food industry to reduce salt (voluntary), and 4) mandatory reformulation to reduce salt in processed foods. The effectiveness of these policies in reducing salt intake, and hence blood pressure, was determined by systematic literature review. The model calculated the reduction in mortality associated with each policy, quantified as life-years gained over 10 years. Policy costs were calculated using evidence from published sources. Health care costs for specific CHD patient groups were estimated. Costs were compared against a "do nothing" baseline. Results: All policies resulted in a life-year gain over the baseline. Change4life and labeling each gained approximately 1960 life-years, voluntary reformulation 14,560 life-years, and mandatory reformulation 19,320 life-years. Each policy appeared cost saving, with mandatory reformulation offering the largest cost saving, more than 660 million. Conclusions: All policies to reduce dietary salt intake could gain life years and reduce health care expenditure on coronary heart disease.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 50 条
  • [21] Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010
    Fidan, D.
    Unal, B.
    Critchley, J.
    Capewell, S.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2007, 100 (05) : 277 - 289
  • [22] AN ECONOMIC-EVALUATION OF LOVASTATIN FOR CHOLESTEROL LOWERING AND CORONARY-ARTERY DISEASE REDUCTION
    HAY, JW
    WITTELS, EH
    GOTTO, AM
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (09): : 789 - 796
  • [23] Translating policy into practice: a case study in the secondary prevention of coronary heart disease
    Prior, Lindsay
    Wilson, Joanne
    Donnelly, Michael
    Murphy, Andrew W.
    Smith, Susan M.
    Byrne, Mary
    Byrne, Molly
    Cupples, Margaret E.
    HEALTH EXPECTATIONS, 2014, 17 (02) : 291 - 301
  • [24] Estimated reductions in cardiovascular and gastric cancer disease burden through salt policies in England: an IMPACTNCD microsimulation study
    Kypridemos, Chris
    Guzman-Castillo, Maria
    Hyseni, Lirije
    Hickey, Graeme L.
    Bandosz, Piotr
    Buchan, Iain
    Capewell, Simon
    O'Flaherty, Martin
    BMJ OPEN, 2017, 7 (01):
  • [25] Reduction of coronary heart disease risk factors in the German Cardiovascular Prevention Study
    Hoffmeister, H
    Mensink, GBM
    Stolzenberg, H
    Hoeltz, J
    Kreuter, H
    Laaser, U
    Nussel, E
    Hullemann, KD
    vonTroschke, J
    PREVENTIVE MEDICINE, 1996, 25 (02) : 135 - 145
  • [26] The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
    Mikhailidis, DP
    Wierzbicki, AS
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) : 215 - 219
  • [27] Forecasting the Future Economic Burden of Current Adolescent Overweight: An Estimate of the Coronary Heart Disease Policy Model
    Lightwood, James
    Bibbins-Domingo, Kirsten
    Coxson, Pamela
    Wang, Claire
    Williams, Lawrence
    Goldman, Lee
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 (12) : 2230 - 2237
  • [28] Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality
    He, Feng J.
    Pombo-Rodrigues, Sonia
    MacGregor, Graham A.
    BMJ OPEN, 2014, 4 (04):
  • [29] Economics of environmental policy in Turkey: A general equilibrium investigation of the economic evaluation of sectoral emission reduction policies for climate change
    Telli, Cagatay
    Voyvoda, Ebru
    Yeldan, Ernic
    JOURNAL OF POLICY MODELING, 2008, 30 (02) : 321 - 340
  • [30] PREDICTING FUTURE TRENDS AND INEQUALITIES IN PREMATURE CORONARY HEART DISEASE DEATHS IN ENGLAND: MODELLING STUDY
    Allen, K.
    Gillespie, D. O. S.
    Castillo, M. Guzman
    Diggle, P. J.
    Capewell, S.
    O'Flaherty, M.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2014, 68 : A35 - A35